Mark L. Berch

Array ( [id] => 7256508 [patent_doc_number] => 20050143367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 10/934031 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18922 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143367.pdf [firstpage_image] =>[orig_patent_app_number] => 10934031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205834 [patent_doc_number] => 20070027316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Process for the preparation of (1s, 4r)-cis-4-\'2-amino-6chloro-9h-purin-yl!-2-cyclopentene-1- methanol' [patent_app_type] => utility [patent_app_number] => 10/570229 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3064 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027316.pdf [firstpage_image] =>[orig_patent_app_number] => 10570229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256777 [patent_doc_number] => 20050143400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Process for preparing famciclovir' [patent_app_type] => utility [patent_app_number] => 10/932120 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2463 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143400.pdf [firstpage_image] =>[orig_patent_app_number] => 10932120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326782 [patent_doc_number] => 07514553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Process for producing penicillanic acid compound' [patent_app_type] => utility [patent_app_number] => 10/569692 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3360 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514553.pdf [firstpage_image] =>[orig_patent_app_number] => 10569692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7237948 [patent_doc_number] => 20050080053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases' [patent_app_type] => utility [patent_app_number] => 10/928177 [patent_app_country] => US [patent_app_date] => 2004-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11187 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080053.pdf [firstpage_image] =>[orig_patent_app_number] => 10928177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220266 [patent_doc_number] => 20070161577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Tethered dimers and trimers of 1,4-diphenylazetidin-2-ones' [patent_app_type] => utility [patent_app_number] => 10/569561 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12656 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161577.pdf [firstpage_image] =>[orig_patent_app_number] => 10569561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172379 [patent_doc_number] => 20070072812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones' [patent_app_type] => utility [patent_app_number] => 10/569557 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9811 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072812.pdf [firstpage_image] =>[orig_patent_app_number] => 10569557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765613 [patent_doc_number] => 20080176825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Oral Neurotherapeutic Cefazolin Compositons' [patent_app_type] => utility [patent_app_number] => 10/569118 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9810 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176825.pdf [firstpage_image] =>[orig_patent_app_number] => 10569118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117404 [patent_doc_number] => 20050070705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Process for the preparation of 3-methylcepham derivatives' [patent_app_type] => utility [patent_app_number] => 10/922992 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1554 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070705.pdf [firstpage_image] =>[orig_patent_app_number] => 10922992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 900569 [patent_doc_number] => 07339055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-04 [patent_title] => 'Process for the preparation of cephalosporin antibiotic' [patent_app_type] => utility [patent_app_number] => 10/922991 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4357 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/339/07339055.pdf [firstpage_image] =>[orig_patent_app_number] => 10922991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 895394 [patent_doc_number] => 07342006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Substituted 8-heteroaryl xanthines' [patent_app_type] => utility [patent_app_number] => 10/923592 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24057 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/342/07342006.pdf [firstpage_image] =>[orig_patent_app_number] => 10923592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181001 [patent_doc_number] => 20050124637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Compounds and compositions as inhibitors of receptor tyrosine kinase activity' [patent_app_type] => utility [patent_app_number] => 10/917578 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20744 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124637.pdf [firstpage_image] =>[orig_patent_app_number] => 10917578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695879 [patent_doc_number] => 07071329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Process for preparing cephalosporins with salified intermediate' [patent_app_type] => utility [patent_app_number] => 10/916532 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7182 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071329.pdf [firstpage_image] =>[orig_patent_app_number] => 10916532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127893 [patent_doc_number] => 20050059637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Nucleobase phosphonate analogs for antiviral treatment' [patent_app_type] => utility [patent_app_number] => 10/903288 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37839 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059637.pdf [firstpage_image] =>[orig_patent_app_number] => 10903288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 377123 [patent_doc_number] => 07312223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction' [patent_app_type] => utility [patent_app_number] => 10/901574 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5003 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312223.pdf [firstpage_image] =>[orig_patent_app_number] => 10901574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760910 [patent_doc_number] => 20060211855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Method for the production of oh protected{4-(2.6-diamino-9h-purine-9-yl)-1.3-dioxolane-2-yl] methanol derivatives' [patent_app_type] => utility [patent_app_number] => 10/595067 [patent_app_country] => US [patent_app_date] => 2004-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7986 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211855.pdf [firstpage_image] =>[orig_patent_app_number] => 10595067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971977 [patent_doc_number] => 20070111980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Process for preparing pure cephalosporine intermediates' [patent_app_type] => utility [patent_app_number] => 10/565086 [patent_app_country] => US [patent_app_date] => 2004-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3305 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111980.pdf [firstpage_image] =>[orig_patent_app_number] => 10565086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 576196 [patent_doc_number] => 07459550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Process for the preparation of Cefditoren' [patent_app_type] => utility [patent_app_number] => 10/563371 [patent_app_country] => US [patent_app_date] => 2004-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2422 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459550.pdf [firstpage_image] =>[orig_patent_app_number] => 10563371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7144003 [patent_doc_number] => 20050118669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Novel fluorogenic substrates for beta-lactamase gene expression' [patent_app_type] => utility [patent_app_number] => 10/884019 [patent_app_country] => US [patent_app_date] => 2004-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21885 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118669.pdf [firstpage_image] =>[orig_patent_app_number] => 10884019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 436036 [patent_doc_number] => 07262293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Aztreonam L-lysine and methods for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/882591 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1505 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262293.pdf [firstpage_image] =>[orig_patent_app_number] => 10882591 [rel_patent_id] =>[rel_patent_doc_number] =>)